Advances in Leukemia Research and Treatment

Dr. Jan S Moreb is a professor in division of Hematology/Oncology, Department of Medicine University of Florida, USA. Dr.Jan Suliman Moreb received his M.D. from Hebrew University Hadassah Medical School, Jerusalem, Israel. Dr. Jan S Moreb is awarded with Equity Award for Outstanding Performance Department of Medicine, University of Florida in 2000. He is honored by Prof Michael H. Ross who dedicated his Book to him Histology: A Textbook and Atlas in 2009. He is gifted $25,000 for the Ladies Auxiliary to the Veterans of Foreign Wars Gift for the Cancer Immunology Program. His research interest includes breast cancer, Multiple Myeloma, DNA repair, Hematologic malignancies, immunotherapy targeting multiple myeloma, Stem Cell and Cancer Biology.

Dr. Xuejun H Parsons received her PhD in Biochemistry, Molecular, and Cell Biology from Cornell University in 1998, and completed her PostDoc studies as a Leukemia and Lymphoma Society Research Fellow at University of California at San Diego in 2002. Parsons Xuejun Huang is awarded with North American Technology Innovation Award in 2013, International Elite Entrepreneurship & Leadership Award in 2015, and honored by The Leukemia and Lymphoma Society Research Fellow from 1999-2002. Dr. Parsons research interest includes PluriXcel human stem cell technology, stem-cell-mediated therapeutic strategies etc.

Dr. Alfio Ferlito is a Professor and Chairman of ENT Clinic at the University of Udine School of Medicine from 1997. Dr. Ferlito was Director of the Surgical Sciences Department at the same University from 2003 to 2009. He graduated in medicine at the University of Bologna in 1968. He completed his residence programmer in otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Professor Ferlito has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 516 international experts. His chief interests is the promotion of international cooperation in head and neck surgery, oncology and cancer research.

Dr. Diaa Youssef received his Ph.D from Albert Ludwig University in Freiburg, Germany in 1995. He worked as Dean in the Suez Canal University, Egypt from 2008-2010.Dr. Diaa Youssef received Research Excellence Awards, KAU, Saudi Arabia in 2014, Research Excellence Awards, SCU, Egypt in 2010.Dr. Diaa Youssef Research interests include Marine biotechnology and marine natural products, Development of Anticancer and antibiotics from marine organisms, Marine microbial natural products, Natural products biosynthesis, Symbiosis in marine invertebrates, Marine toxins, Marine chemical ecology, Water pollution and its impact on public health.

Dr. Tadeusz Robak is Professor of Hematology at the Medical University of Lodz, Poland. He received his Ph.D. in 1979 from Medical University of Lodz, Poland. He currently holds the posts of Professor of Hematology at the Medical University of Lodz and Chief of Department of Hematology at the Copernicus Memorial Hospital in Lodz, Poland. The particular research emphasis has been on the application of new drugs in the treatment of leukemia multiple myeloma and lymphoma and interactions of antineoplastic agents. Professor Robak published more than 550 journal articles, 480 abstracts and 25 books and chapters. He received award “Eminent Scientist of the Year 2010” from International Research Promotion Council (IRPC). Dr. Tadeusz Robak research interests include Clinical Oncology, Cancer Treatment, Blood, Leukemia, Leukaemia and Lymphoma, Lancet, Lancet Oncology and others.

Dr. Meenakshi Devidas received her M.s in 1986 and Ph.D in 1991 from University of Memphis, USA. Dr. Devidas is the Lead Statistician for the disease area of Acute Lymphoblastic Leukemia (ALL) and resource statistician for Bone tumors (Ewing Sarcoma and Osteosarcoma). She is responsible for reviewing concept proposals, trial design, sample size calculations, and developing / implementing safety and efficacy monitoring rules for new clinical trials in these disease areas. Her research interests include efficient two-stage designs for Phase II trials which need to be monitored for insufficient activity (low response rates) and/or excessive early disease progression rates.

Dr. Xuchu Que is a Senior Faculty and Scientist in Department of Medicine, University of California San Diego. Prior to UCSD, Dr. Que obtained his Ph.D. degree in Molecular Biology from Center for Disease Control and Prevention (China CDC), and postdoc training at Northwestern University in Chicago. Dr. Que’s research interest focus on innate immunity to the endogenous formed oxidized phospholipids on apoptotic cells from lipid peroxidation in atherosclerosis and inflammatory disease, as well as the effect of oxidation epitopes on the development of B cells in chronic lymphocytic leukemia.

Dr. Andrii Puzyrenko is a Resident Physician in Pathology and Laboratory Medicine at Medical College of Wisconsin, Milwaukee, USA. He also worked as an Associate Professor in Pharmacology Department at All Saints University School of Medicine, Roseau, Dominica. He completed his Ph.D. program in pathology and pharmacology from Bogomolets National Medical University, Ukraine and Residency program in Otolaryngology/Head and Neck Oncology from National Medical Academy of Postgraduate Education, Ukraine.

Dr. Jennifer schroeder received her Ph.D in 2004 from University of Illinois, USA. Jennifer received her M.S in 2001 from University of Illinois. Dr. Jennifer schroeder received Integrative Physiology Award for outstanding contribution to Molecular and Integrative Physiology in 2002, outstanding poster presentation award for Cell and Molecular Biology and Molecular Biophysics Research Symposium, certificate of appreciation from Pi Beta Phi for academic support in 2013. Dr. Jennifer schroeder research interests include why estrogenic hormones produce differing results, development of an atrazine detecting ELISA to use with local water samples, molecular biology and molecular biophysics.

Dr. Jianying Zhang received her Ph.D in Clinical Pharmacology and Biochemistry from Kochi Medical School, Japan in 1999. Dr. Jianying Zhang received her M.S. in Pharmaceutical Chemistry from Peking University School of Pharmacy, China in 1990. She is a member in American Society for Bone and Mineral Research from 2015, International Chinese Musculoskeletal Research Society member from 2013, American Orthopaedic Research Society member from 2009. Dr. Jianying Zhang's research interests include Stem cell isolation, characterization and medical application, Pathogenic mechanisms of tendinopathy, Biomechanics and sports medicine, Biomaterial synthesis and medical application, Tissue engineering and regenerative medicine, Drug delivery and control-release.

Dr. Malgorzata Salamonowicz-Bodzioc is MD (physician/pediatrician) in Department of Children Oncology, Hematology and Transplantology at Supraregional Center of Children Oncology and Hematology, Wroclaw, Poland. She is also working as Academic teacher in Department of Children Oncology, Hematology and Transplantology at Medical University Wroclaw. Dr. Malgorzata completed her MD and PHD from Medical University of Warsaw and Post graduate internship from Community Hospital, Warsaw. Her research interests include Pediatric stem cell Transplantation/ Pediatric severe aplastic anemia, SAA/Hemophagocytic Lymphohistiocytosis, HLH/ Pediatric acute lymphoblastic leukemia, ALL/infectious complications after chemotherapy, infectious complications after stem cell allogenic transplantation.

Jifan Hu is Professor in Stem Cell and Cancer Center of the Norman Bethune First Hospital at Jilin University, and the Director of Cancer and Stem Cell Epigenetics Program. He received his Ph.D. from Cornell University, M.S. from Beijing University, and M.D. from Anhui Medical University. He took the postdoctoral training at Stanford University Medical School. As the PI, he has been in charge of research grants from NIH, US Department of Defense (DoD), California Institute for Regenerative Medicine (CIRM), National Natural Science Foundation of China (NFSC), and National Basic Research Program of China. His research interests include stem cell reprograming and self-renewal, noncoding RNAs, and mechanisms underlying genomic imprinting and gene regulation in cancers. He has published a series of papers in peer-reviewed journals, including Cell Stem Cell, Biomaterials, J Cell Biol, Nucleic Acids Res, Oncotarget, Oncogene, Hepatology, and Science. In a project funded by CIRM, his group demonstrates that intrachromosomal looping in pluripotency gene promoters is a critical epigenetic barrier in iPS cell reprogramming.